Anticancer agent 44
Anticancer agent 44 (compound 2a) is a potent anticancer agent. Anticancer agent 44 shows cytotoxicity activity in cancer cells. Anticancer agent 44 induces apoptosis. Anticancer agent 44 shows low toxicity towards activated lymphocytes of human blood[1].
Product Specifications
CAS Number
2770943-86-5
UNSPSC
12352005
Target
Apoptosis
Type
Reference compound
Related Pathways
Apoptosis
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/anticancer-agent-44.html
Solubility
10 mM in DMSO
Smiles
O=C1CC(C(N1C2=CC=C(C=C2)Cl)=O)N3C(/C(SC3=S)=C/C(Cl)=C/C4=CC=C(C=C4)[N+]([O-])=O)=O
Molecular Formula
C22H13Cl2N3O5S2
Molecular Weight
534.39
References & Citations
[1]Finiuk N, et al. Novel hybrid pyrrolidinedione-thiazolidinones as potential anticancer agents: Synthesis and biological evaluation. Eur J Med Chem. 2022 May 2;238:114422.|[2]Nataliya Finiuk, et al. Novel hybrid pyrrolidinedione-thiazolidinones as potential anticancer agents: Synthesis and biological evaluation. Eur J Med Chem. 2022 May 2;238:114422.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6480231-01 0.2 mL
Hexokinase 3, NT (Hexokinase-3, HK3, HXK3, Hexokinase Type III, HK III, HKIII) (FITC)
Sign In for Pricing
View Details MBS6480231-02 5x 0.2 mL
Hexokinase 3, NT (Hexokinase-3, HK3, HXK3, Hexokinase Type III, HK III, HKIII) (FITC)
Sign In for Pricing
View Details 